Group One Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $234K | Buy |
|
|||||
|
2023
Q4 | $188K | Buy |
|
|||||
|
2023
Q3 | $84.2K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $842K | Sell |
|
|||||
|
2022
Q4 | $1.87M | Buy |
|
|||||
|
2022
Q3 | $899K | Sell |
|
|||||
|
2022
Q2 | $1.55M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.92M | Buy |
|
|||||
|
2021
Q3 | $1.68M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $1.61M | Buy |
|
|||||
|
2020
Q3 | $471K | Buy |
|
|||||
|
2020
Q2 | $393K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $19K | Buy |
|
|||||
|
2019
Q3 | $9K | Sell |
|
|||||
|
2019
Q2 | $395K | Buy |
|
|||||
|
2019
Q1 | $23K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $30K | Sell |
|
|||||
|
2018
Q2 | $42K | Buy |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2017
Q4 | $7K | Sell |
|
|||||
|
2017
Q3 | $248K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $806K | Buy |
|
|||||
|
2016
Q4 | $514K | Buy |
|
|||||
|
2016
Q3 | $16K | Sell |
|
|||||
|
2016
Q2 | $37K | Buy |
|
|||||
|
2016
Q1 | $17K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $32K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $88K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $147K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $70K | Sell |
|
|||||
|
2013
Q4 | $541K | Buy |
|
|||||
|
2013
Q3 | $253K | Buy |
|
|||||
|
2013
Q2 | $23K | Buy |
|